BPC-157 and TB-500 recovery claims: what the science says

What did @coach_ramzay actually say?

The creator recommended two peptides, which they called "C-Max" and "C-Lank" (almost certainly semax and selank), for cognitive focus and anxiety management respectively. They described semax as something that helps you "have a better mood, stay focused, on target" and noted it's delivered as a nasal spray. Selank, they said, "works well in keeping you calm" and is "kind of like an anti-anxiety peptide." They also suggested stacking both, taking one in the morning and one at night. No doses were mentioned, no physician involvement was discussed, and the framing positioned these as casual lifestyle tools anyone can self-administer.

To be fair, the creator didn't make wild disease-cure claims. But calling selank something you reach for "when you're going to places where you're not going to be very comfortable" glosses over the fact that these are pharmacologically active peptides with real regulatory and safety considerations, not supplements you grab off a shelf.

Does the science back this up?

There is legitimate research behind both peptides, mostly from Russian institutions, which matters because it affects how we should interpret that data. Semax has the stronger human evidence base of the two.

Semax is a synthetic analogue of ACTH(4-7) and has been studied primarily in Russia for neurological applications. Dolotov et al. (2006, Neuroscience) demonstrated that semax upregulates BDNF and its receptor TrkB in rat brain tissue, providing a plausible mechanism for the cognitive and mood effects the creator described. A 2011 study by Eremin et al. published in the Russian journal Molecular Biology showed semax influenced expression of genes involved in synaptic plasticity. Human clinical trials exist, but most are small, conducted in Russian populations, and focused on stroke recovery rather than healthy optimization.

Selank is a synthetic analogue of tuftsin and has shown anxiolytic effects in animal studies and some small human trials. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reported reductions in anxiety measures in patients with generalized anxiety disorder, but the trial was not placebo-controlled in a way that would satisfy Western regulatory standards. The mechanism proposed involves modulation of GABA-A receptors and serotonin metabolism, which is plausible but not definitively established in humans.

What did they get right and wrong?

Credit where it's due: the creator correctly identified that both semax and selank are typically delivered intranasally, which is accurate. The nasal route is well-documented for these peptides because it allows direct transport along the olfactory pathway, bypassing the blood-brain barrier more efficiently than subcutaneous injection for these specific compounds. That's not nothing. Most peptide content gets the delivery route wrong entirely.

What they got wrong is the framing of certainty. Describing selank as something that will help with social anxiety in public places treats a compound with limited, largely non-Western human trial data as if it were a validated therapeutic. It isn't. Selank is not FDA-approved. Semax is not FDA-approved. Neither has completed Phase III trials in the United States.

The creator also didn't mention that sourcing matters enormously here. These peptides are not regulated the same way pharmaceuticals are, which means purity, concentration, and sterility vary significantly depending on vendor. Recommending these without flagging that point is a real omission.

What should you actually know?

If you're curious about semax or selank, the honest picture is this: the mechanistic rationale is real, the early research is genuinely interesting, and the risk profile appears relatively low based on available data. But "relatively low risk" and "proven to work in healthy adults" are two completely different statements.

Both peptides fall into a regulatory gray zone in the United States. They are not approved drugs, not classified as dietary supplements, and not legal to sell for human consumption in most commercial contexts. Compounded versions exist, but quality control is the responsibility of the compounding pharmacy, not a federal regulatory body reviewing efficacy data.

Anyone considering these should have that conversation with a licensed clinician who can review their full health history, not get their protocol from a TikTok comment section. The creator's offer to answer questions in comments is not a substitute for that. A peptide that modulates BDNF or GABA-A signaling is not a trivial compound, even if it's delivered via a nasal spray and feels benign.